GHOSH ANIRVAN (Chief Executive Officer) sold 1.5% of their position (1.18K shares) of UNITY BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $2.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/31/2024ACC: 0000950170-24-009378
DirectorOfficer· Chief Executive Officer
Since Mar 2020
-1.18K
Net shares
Net seller
$2.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.18K disposed
Non-Derivative Transactions1
Common Stock, $0.0001 par value
Direct
Shares
−1.18K
Price / share
$1.71
Trade value
$2.02K
% of position
1.5%
1/30/2024
80.61K→79.43K
Total
Net shares
−1.18K
Net value
-$2.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Direct | 1/30/2024 | S · Sale | −1.18K | $1.71 | $2.02K | 1.5% | 80.61K | 79.43K |
| Total | −1.18K | -$2.02K | ||||||
Derivative Transactions0
No derivative transactions reported